Literature DB >> 12466637

Treating medication-resistant panic disorder: predictors and outcome of cognitive-behavior therapy in a Brazilian public hospital.

Elizeth Heldt1, Gisele Gus Manfro, Leticia Kipper, Carolina Blaya, Sandra Maltz, Luciano Isolan, Vânia Naomi Hirakata, Michael W Otto.   

Abstract

BACKGROUND: In Brazil, treatment of panic disorder is most frequently initiated with pharmacotherapy, but only half of the patients can be expected to be panic free after medication. Studies have suggested that individual or group cognitive-behavior therapy (CBT) is an effective treatment strategy for panic patients who have failed to respond to pharmacotherapy.
METHODS: Thirty-two patients diagnosed with panic disorder with agoraphobia having residual symptoms despite being on an adequate dose of medication were treated with 12 weeks of group CBT. The outcome was evaluated for panic frequency and severity, generalized anxiety, and global severity. Comorbid conditions, a childhood history of anxiety, and defense mechanism styles were assessed as potential predictors of treatment response.
RESULTS: Twenty-nine patients completed the 12-week protocol. Treatment was associated with significant reductions in symptom severity on all outcome measures (p < 0.001). Patients with depression had a poorer outcome of the treatment (p = 0.01) as did patients using more neurotic (p = 0.002) and immature defenses (p = 0.05).
CONCLUSION: Consistent with previous reports, we found that CBT was effective for our sample of treatment-resistant patients. Among these patients, depression as well as neurotic defense style was associated with a poorer outcome. The use of CBT in Brazil for treatment-resistant and other panic patients is encouraged. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12466637     DOI: 10.1159/000067188

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  13 in total

Review 1.  Childhood internalizing behaviour: analysis and implications.

Authors:  J Liu; X Chen; G Lewis
Journal:  J Psychiatr Ment Health Nurs       Date:  2011-05-20       Impact factor: 2.952

Review 2.  Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults.

Authors:  Hui Li; Jijun Wang; Chunbo Li; Zeping Xiao
Journal:  Cochrane Database Syst Rev       Date:  2014-09-17

Review 3.  Examining the "usual" in usual care: a critical review and recommendations for usual care conditions in psycho-oncology.

Authors:  Joanna J Arch; Annette L Stanton
Journal:  Support Care Cancer       Date:  2019-02-20       Impact factor: 3.603

4.  Cognitive-behavioral therapy for adult anxiety disorders in clinical practice: a meta-analysis of effectiveness studies.

Authors:  Rebecca E Stewart; Dianne L Chambless
Journal:  J Consult Clin Psychol       Date:  2009-08

5.  Predictors of clinical improvement in a randomized effectiveness trial for primary care patients with panic disorder.

Authors:  Denise A Chavira; Murray B Stein; Daniela Golinelli; Cathy D Sherbourne; Michelle G Craske; Greer Sullivan; Alexander Bystritsky; Peter P Roy-Byrne
Journal:  J Nerv Ment Dis       Date:  2009-10       Impact factor: 2.254

6.  Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.

Authors:  Naomi M Simon; Michael W Otto; John J Worthington; Elizabeth A Hoge; Elizabeth H Thompson; Richard T Lebeau; Samantha J Moshier; Alyson K Zalta; Mark H Pollack
Journal:  J Clin Psychiatry       Date:  2009-10-06       Impact factor: 4.384

Review 7.  Pharmacotherapy of anxiety disorders: a critical review.

Authors:  Nastassja Koen; Dan J Stein
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

8.  Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder.

Authors:  Yumiko Noda; Yumi Nakano; Kiyoe Lee; Sei Ogawa; Yoshihiro Kinoshita; Tadashi Funayama; Norio Watanabe; Junwen Chen; Yuka Noguchi; Miyako Kataoka; Masako Suzuki; Toshi A Furukawa
Journal:  BMC Psychiatry       Date:  2007-12-10       Impact factor: 3.630

9.  Pharmacological management of panic disorder.

Authors:  Carlo Marchesi
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570

10.  "Nomophobia": impact of cell phone use interfering with symptoms and emotions of individuals with panic disorder compared with a control group.

Authors:  Anna Lucia Spear King; Alexandre Martins Valença; Adriana Cardoso Silva; Federica Sancassiani; Sergio Machado; Antonio Egidio Nardi
Journal:  Clin Pract Epidemiol Ment Health       Date:  2014-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.